白念珠菌唑类药物相关耐药基因及其调控机制的研究进展

doi:10.3969/j.issn.1673-8640.2016.09.002

摘要/Abstract

摘要：

白念珠菌是人体常见的条件致病性真菌。随着唑类抗真菌药物的长期、广泛应用,白念珠菌耐唑类抗真菌药物的临床分离株也逐渐增多,已经成为临床抗白念珠菌治疗的棘手问题。现就白念珠菌唑类药物相关耐药基因及其调控机制进行综述,以便在转录调控层面寻找新的白念珠菌感染的治疗靶点及开发新的抗真菌药物。

关键词: 白念珠菌, 唑类药物, 耐药基因, 调控机制

Abstract:

Candida albicans is a conditionally pathogenic fungus in human. With azoles being widely applied for a long time,the clinical isolates of Candida albicans against azoles gradually increase. The clinical treatment of Candida albicans has become a thorny issue. The drug resistance genes of Candida albicans and regulation mechanisms are reviewed for finding new therapeutic targets and developing new antifungal agents at the level of transcriptional regulation.

Key words: Candida albicans, Azoles, Drug resistance genes, Regulation mechanisms

中图分类号:

R379.4

吴永琴, 应春妹. 白念珠菌唑类药物相关耐药基因及其调控机制的研究进展[J]. 检验医学, 2016, 31(9): 739-743.

WU Yongqin, YING Chunmei. Drug resistance genes of Candida albicans to azoles and their regulation mechanisms[J]. Laboratory Medicine, 2016, 31(9): 739-743.

图/表 1

参考文献 35

1	FUENTES M,HERMOSILLA G,ALBURQUENQUE C,et al.Characterization of azole resistance mechanisms in Chilean clinical isolates of Candida albicans[J]. Rev Chilena Infectol, 2014,31(5):511-517.
2	ST GEORGIEV V.Membrane transporters and antifungal drug resistance[J]. Curr Drug Targets,2000,1(3):261-284.
3	MARR KA,LYONS CN,HA K,et al.Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans[J]. Antimicrob Agents Chemother,2001,45(1):52-59.
4	LIU TT,ZNAIDI S,BARKER KS,et al.Genome-wide expression and location analyses of the Candida albicans Tac1p regulon[J]. Eukaryot Cell,2007,6(11):2122-2138.
5	MORSCHHÄUSER J. Regulation of multidrug resistance in pathogenic fungi[J]. Fungal Genet Biol,2010,47(2):94-106.
6	COSTE AT,CRITTIN J,BAUSER C,et al.Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system[J]. Eukaryot Cell,2009,8(8):1250-1267.
7	MORIO F,PAGNIEZ F,BESSE M,et al.Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1,MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans[J]. Int J Antimicrob Agents,2013,42(5):410-415.
8	JENSEN RH,ASTVAD KM,SILVA LV,et al.Stepwise emergence of azole,echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations[J]. J Antimicrob Chemother,2015,70(9):2551-2555.
9	SCHILLIG R,MORSCHHÄUSER J. Analysis of a fungus-specific transcription factor family,the Candida albicans zinc cluster proteins,by artificial activation[J]. Mol Microbiol,2013,89(5):1003-1017.
10	WANG Y,LIU J,SHI C,et al.Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans[J]. Int J Antimicrob Agents,2015,46(5):552-559.
11	DUNKEL N,BLASS J,ROGERS PD,et al.Mutations in the multi-drug resistance regulator MRR1,followed by loss of heterozygosity,are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains[J]. Mol Microbiol,2008,69(4):827-840.
12	MORIO F,PAGNIEZ F,BESSE M,et al.Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1,MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans[J]. Int J Antimicrob Agents,2013,42(5):410-415.
13	CHEN CG,YANG YL,TSENG KY,et al.Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans[J]. Fungal Genet Biol,2009,46(9):714-720.
14	LO HJ,TSENG KY,KAO YY,et al.Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans[J]. Int J Antimicrob Agents,2015,45(6):617-621.
15	CALABRESE D,BILLE J,SANGLARD D.A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole[J]. Microbiology,2000,146( Pt 11):2743-2754.
16	XU Y,SHENG F,ZHAO J,et al.ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates[J]. Arch Microbiol,2015,197(9):1087-1093.
17	ZHANG JY,LIU JH,LIU FD,et al.Vulvovaginal candidiasis:species distribution,fluconazole resistance and drug efflux pump gene overexpression[J]. Mycoses,2014,57(10):584-591.
18	SANGLARD D,ISCHER F,PARKINSON T,et al.Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents[J]. Antimicrob Agents Chemother,2003,47(8):2404-2412.
19	MORIO F,PAGNIEZ F,LACROIX C,et al.Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance:characterization of two novel mutants with impaired virulence[J]. J Antimicrob Chemother,2012,67(9):2131-2138.
20	MARTEL CM,PARKER JE,BADER O,et al.Identification and characterization of four azole-resistant erg3 mutants of Candida albicans[J]. Antimicrob Agents Chemother,2010,54(11):4527-4533.
21	陈晋宇,冯文莉,杨静,等. 临床白念珠菌耐药性与ERG3基因突变及表达的关系[J]. 国际医药卫生导报,2014,20(13):1838-1844.
22	LIU JY,SHI C,WANG Y,et al.Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai,China[J]. Res Microbiol,2015,166(3):153-161.
23	SANGLARD D,ISCHER F,KOYMANS L,et al.Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase(CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents[J]. Antimicrob Agents Chemother,1998,42(2):241-253.
24	TEYMURI M,MAMISHI S,POURAKBARI B,et al.Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans: first report from an Iranian referral paediatric hospital[J]. Br J Biomed Sci,2015,72(1):28-31.
25	MORIO F,LOGE C,BESSE B,et al.Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates:new substitutions and a review of the literature[J]. Diagn Microbiol Infect Dis,2010,66(4):373-384.
26	FLOWERS SA,COLON B,WHALEY SG,et al.Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans[J]. Antimicrob Agents Chemother,2015,59(1):450-460.
27	刘锦燕,倪培华,史册,等. 白念珠菌14-α脱甲基酶 K143Q 氨基酸置换与氟康唑耐药形成的相关性研究[J]. 检验医学,2014,29(7):750-754.
28	OLIVER BG,SONG JL,CHOINIERE JH,et al.cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p[J]. Eukaryot Cell,2007,6(12):2231-2239.
29	MACPHERSON S,AKACHE B,WEBER S,et al.Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes[J]. Antimicrob Agents Chemother,2005,49(5):1745-1752.
30	FLOWERS SA,BARKER KS,BERKOW EL,et al.Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans[J]. Eukaryot Cell,2012,11(10):1289-1299.
31	NOBILE CJ,NETT JE,ANDES DR,et al.Function of Candida albicans adhesin Hwp1 in biofilm formation[J]. Eukaryot Cell,2006,5(10):1604-1610.
32	FANNING S,XU W,SOLIS N,et al.Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo[J]. Eukaryot Cell,2012,11(7):896-904.
33	CHEN HF,LAN CY.Role of SFP1 in the regulation of Candida albicans biofilm formation[J]. PLoS One,2015,10(6):e129903.
34	DESAI JV,MITCHELL AP.Microbial biofilms:Candida albicans biofilm development and its genetic control[M]. 2nd ed. Washington DC:ASM Science,2015:99-110.
35	SCHNEIDER S,MORSCHHÄUSER J. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors[J]. Antimicrob Agents Chemother,2015,59(1):558-569.

[1]	朱昱蓉, 张丹, 贺雅星, 李晶晶, 黄晶, 李婷, 刘鹏, 刘荣华. 肺炎克雷伯菌临床分离株分子分群和流行病学特征[J]. 检验医学, 2023, 38(5): 435-440.
[2]	方咏梅, 章燕, 徐雪莹, 钟峰. 金黄色葡萄球菌耐药性与耐药基因和毒力基因的相关性[J]. 检验医学, 2023, 38(4): 357-361.
[3]	王佳玮, 朱威南, 陈颖盈, 季萍, 王颖. 血培养分离碳青霉烯类耐药肺炎克雷伯菌临床分布和耐药基因分析[J]. 检验医学, 2023, 38(4): 362-367.
[4]	杨思敏, 轩乾坤, 羽晓瑜, 温冬华, 李广波. 国产某品牌大肠埃希菌和肺炎克雷伯菌及3种碳青霉烯耐药基因试剂性能验证[J]. 检验医学, 2023, 38(1): 56-59.
[5]	宋皓月, 舒文. 肉芽肿性乳腺炎患者结核硬脂酸棒状杆菌毒力因子和耐药性分析[J]. 检验医学, 2022, 37(11): 1075-1078.
[6]	张亚茹, 凌丽燕, 陈敏. EUCAST和CLSI微量肉汤稀释法白念珠菌体外药物敏感性试验结果比较[J]. 检验医学, 2022, 37(10): 974-978.
[7]	张冠怡, 姚冬婷, 王健, 胡晓波. 光滑念珠菌耐药机制及中西药治疗光滑念珠菌感染研究进展[J]. 检验医学, 2021, 36(7): 761-765.
[8]	陆书华, 李晓哲, 刘凌云, 金呈强, 戈宁宁, 董海新. 山东某院耐碳青霉烯类肠杆菌科细菌临床感染特征及耐药基因分析[J]. 检验医学, 2020, 35(8): 757-762.
[9]	李贞, 殷红梅, 陈伟琴, 薛赢俊, 胡骏, 诸斌, 胡晓波. 土槿皮乙酸与氟康唑联合应用于体外抗白念珠菌活性研究[J]. 检验医学, 2020, 35(7): 663-667.
[10]	薛玉芹, 黄韵, 张正银, 王亚婷, 金英, 桂芸, 余彬. 致伤口感染犬巴斯德菌耐药基因全基因测序分析[J]. 检验医学, 2020, 35(7): 699-701.
[11]	杜金龙, 冯燕, 李恒涛. 实时荧光定量PCR结合探针检测MP的临床价值及MP耐药情况分析[J]. 检验医学, 2020, 35(6): 535-539.
[12]	池宏波, 杨英梅. 台州地区结核分枝杆菌分离及耐药特征分析[J]. 检验医学, 2020, 35(5): 455-457.
[13]	孙康德, 张家胜, 陈旭, 虞中敏, 陈福祥. 口腔白念珠菌耐药性及毒力因子表达水平相关性研究[J]. 检验医学, 2019, 34(8): 730-735.
[14]	黄春兰, 徐秋红, 余洪立, 马丽梅, 廖致红. 1株血液感染大肠弯曲菌生物学特性及全基因组序列相关性分析[J]. 检验医学, 2019, 34(12): 1091-1096.
[15]	苏思婷, 温洪宇, 袁振亚, 王秀颖, 王国振, 俞晨洁. 使用抗菌药物对婴幼儿肠道微生态的影响[J]. 检验医学, 2018, 33(8): 764-767.